A 24-year-old female with persistent asthma uses low-dose inhaled budesonide daily but reports daytime symptoms four days a week and nighttime awakenings. What is the preferred next step in therapy?

Answer and explanation

Correct answer: A. Add a long-acting beta2 agonist

  1. Step 1: Uncontrolled asthma symptoms on low-dose inhaled corticosteroid monotherapy require step-up maintenance therapy under GINA guidelines.
  2. Step 2: The preferred step-up regimen is combining an inhaled corticosteroid with a long-acting beta2 agonist, which achieves superior symptom control and prevents exacerbations.
Answer
Add a long-acting beta2 agonist.
Why not the others: Theophylline is an alternative agent with a narrow therapeutic index and significant toxicity risks, making it non-preferred. Daily oral systemic corticosteroids are reserved for severe refractory step 5 asthma due to significant long-term systemic side effects. Discontinuing inhaled steroids leads to worsening bronchial inflammation.

Practise more Cardiovascular and Respiratory Medicine.

Free questions with an explanation for every one, and full timed DHA Dubai mock tests.